Search results for "cancer diagnosis"
Selected Filters:
The evolution of immune cell killing assays using live-cell analysis
Sartorius white paper on enhanced data analytics and translational models
Breath Biopsy® Kits
Owlstone MedicalConsumable components of the Breath Biopsy system, required for robust breath sample collection using the ReCIVA Breath Sampler as part of the Breath Biopsy Collection Station. One Kit per sample.
Discovery of biomarkers in breath and other biological samples
MicroGEM granted Emergency Use Authorization from FDA for fast point of care PCR COVID-19 saliva test
SARS-CoV-2 Saliva Test provides PCR results at the point of care in just 27 minutes and is robust with existing variants
ECCMID Relocates to Amsterdam for Upcoming 2016 Congress
The 2016 Congress will bring together world leading experts and innovative research findings
Reliable Sequencing for Detection and Identification of Cell-Free Tumor DNA
Beckman Coulter Receives FDA Clearance for First IVD Test Delivering Flow Cytometric Leukemia & Lymphoma Analysis
ClearLLab products improve laboratory workflow by reducing manual preparation and routine validation
KRIBIOLISA™ Catumaxomab ELISA (REMOVAB™)
KRISHGEN BioSystemsELISA for the detection of Catumaxomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Thermal imaging to take the heat out of the coronavirus crisis
FLIR Systems' infrared thermal cameras are designed to detect elevated body temperatures and mitigate the spread of the virus
Beckman Coulter Life Sciences revolutionizes nanoparticle analysis with the launch of CytoFLEX nano Flow Cytometer
Instrument breaks the boundaries of EV detection, providing access to new data points
Akoya Biosciences announces a groundbreaking collaboration with PathAI to combine spatial biology with AI-powered tools to facilitate discovery of novel predictive biomarkers
The partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners
Avacta enters into collaboration and option agreement with ADC Therapeutics
New collaboration to focus on developing potent Affimer-drug conjugates